Search
Now showing items 1-2 of 2
Biomimetic tumor engineering to enhance drug discovery (BioengineeredTumor)
(Science Fund of the Republic of Serbia, Program PRISMA, 2024)
Development of novel anti-cancer therapies is still slow and cumbersome partially due to
weaknesses of current preclinical studies based on simple monolayer cell cultures followed by
animal testing. Consequently, there ...
Tracking antimicrobial resistance in diverse ecological niches - one health perspective (TRACE)
(Science Fund of the Republic of Serbia, Program PRISMA, 2024)
The rise of antimicrobial resistance (AMR) has become a global public health crisis. The AMR
evolvability is mainly influenced by the flow of bacteria, antimicrobial resistance genes (ARGs),
and active antimicrobials ...